help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perkins, L. M.
Right arrow Articles by Payne, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perkins, L. M.
Right arrow Articles by Payne, A. H.

Endocrinology, Vol 122, 2257-2264, Copyright © 1988 by Endocrine Society


ARTICLES

Testosterone-enhanced oxygen-mediated degradation of P-450(17) alpha in mouse Leydig cell cultures

LM Perkins, PF Hall and AH Payne
Department of Biological Chemistry, University of Michigan, Ann Arbor 48109-0278.

The present study investigated the process by which the microsomal cytochrome P-450 17 alpha-hydroxylase enzyme (P-450(17) alpha) activity in Leydig cells is decreased by steroid products in an oxygen-dependent manner. Leydig cells were maintained in primary culture at ambient (19% O2) or reduced (1% O2) oxygen tension and treated with 8-bromo-cAMP or steroids for 48 h. The amount and activity of P-450(17) alpha present in the treated cells were measured to determine whether changes in the activity of the enzyme due to treatment correlated with changes in the amount of the enzyme protein. At ambient oxygen tension the amount of P- 450(17) alpha declined in Leydig cells treated with cAMP, and this decrease could be prevented when cultures were maintained at reduced oxygen tension. Treatment of cultures with testosterone caused an oxygen-sensitive decrease in the amount of the enzyme similar in extent to the cAMP-induced decrease. Reductions in the amount of P-450(17) alpha corresponded to reductions in the activity of the enzyme. The decline in the amount of P-450(17) alpha was due to increased decay of the enzyme protein and not to a decrease in the rate of synthesis of P- 450. In contrast to testosterone, neither estradiol nor cortisol affected the amount of P-450(17) alpha. The data are consistent with the proposal that steroid products acting as pseudosubstrates cause decreases in P-450(17) alpha activity by enhancing oxygen radical- mediated damage to the enzyme. The damaged enzyme resulting from this process is more prone to degradation than is the intact protein.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society